{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T13:26:55Z","timestamp":1759411615382},"reference-count":45,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001322","name":"Medical Research Council of South Africa","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001322","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Institute for Communicable Disease (NICD)"},{"name":"Division of the National Health Laboratory Service (NHLS)"},{"name":"University of Witwatersrand, Johannesburg, South Africa"},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1016\/j.vaccine.2010.11.072","type":"journal-article","created":{"date-parts":[[2010,12,8]],"date-time":"2010-12-08T09:18:32Z","timestamp":1291799912000},"page":"2187-2192","source":"Crossref","is-referenced-by-count":22,"title":["Distribution of factor H binding protein beyond serogroup B: Variation among five serogroups of invasive Neisseria meningitidis in South Africa"],"prefix":"10.1016","volume":"29","author":[{"given":"Kedibone M.","family":"Mothibeli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mignon","family":"du Plessis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"von Gottberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellen","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan K.","family":"Hoiseth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary","family":"Zlotnick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith P.","family":"Klugman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"November (11)","key":"10.1016\/j.vaccine.2010.11.072_bib0005","doi-asserted-by":"crossref","first-page":"5146","DOI":"10.1128\/JCM.42.11.5146-5153.2004","article-title":"Distribution of serogroups and genotypes among disease-associated and carried isolates of Neisseria meningitidis from the Czech Republic, Greece, and Norway","volume":"42","author":"Yazdankhah","year":"2004","journal-title":"J Clin Microbiol"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2010.11.072_bib0010","doi-asserted-by":"crossref","first-page":"615","DOI":"10.4269\/ajtmh.2009.80.615","article-title":"Increasing isolations of Neisseria meningitidis serogroup A from blood and cerebrospinal fluid in Dhaka, Bangladesh, 1999\u20132006","volume":"80","author":"Hossain","year":"2009","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2010.11.072_bib0015","series-title":"Meningococcal Infections: Recognizing, Treating and Preventing Infections Caused by Neisseria meningitidis","article-title":"The meningococcal bacterium","author":"Pickering","year":"2000"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2010.11.072_bib0020","doi-asserted-by":"crossref","first-page":"5129","DOI":"10.1128\/JCM.43.10.5129-5135.2005","article-title":"Molecular epidemiology of Neisseria meningitidis isolated in the African Meningitis Belt between 1988 and 2003 shows dominance of sequence type 5 (ST-5) and ST-11 complexes","volume":"43","author":"Nicolas","year":"2005","journal-title":"J Clin Microbiol"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2010.11.072_bib0025","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3201\/eid1302.051553","article-title":"Meningococcal disease in South Africa, 1999\u20132002","volume":"13","author":"Coulson","year":"2007","journal-title":"Emerg Infect Dis"},{"issue":"February (3)","key":"10.1016\/j.vaccine.2010.11.072_bib0030","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1086\/525260","article-title":"Emergence of endemic serogroup W135 meningococcal disease associated with a high mortality rate in South Africa","volume":"46","author":"von Gottberg","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2010.11.072_bib0035","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1086\/345763","article-title":"Safety, reactogenicity, and immunogenicity of a tetravalent meningococcal polysaccharide-diphtheria toxoid conjugate vaccine given to healthy adults","volume":"186","author":"Campbell","year":"2002","journal-title":"J Infect Dis"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2010.11.072_bib0040","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1001\/archpedi.159.10.907","article-title":"Safety, immunogenicity, and immune memory of a novel meningococcal (groups A, C, Y, and W-135) polysaccharide diphtheria toxoid conjugate vaccine (MCV-4) in healthy adolescents","volume":"159","author":"Keyserling","year":"2005","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"August (8346)","key":"10.1016\/j.vaccine.2010.11.072_bib0045","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0140-6736(83)90340-9","article-title":"Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis","volume":"2","author":"Finne","year":"1983","journal-title":"Lancet"},{"issue":"August (3)","key":"10.1016\/j.vaccine.2010.11.072_bib0050","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1086\/600141","article-title":"Sequence diversity of the factor H binding protein vaccine candidate in epidemiologically relevant strains of serogroup B Neisseria meningitidis","volume":"200","author":"Murphy","year":"2009","journal-title":"J Infect Dis"},{"issue":"February (9)","key":"10.1016\/j.vaccine.2010.11.072_bib0055","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1016\/j.vaccine.2009.12.027","article-title":"Frequency of factor H-binding protein modular groups and susceptibility to cross-reactive bactericidal activity in invasive meningococcal isolates","volume":"28","author":"Pajon","year":"2010","journal-title":"Vaccine"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2010.11.072_bib0060","first-page":"924","article-title":"Laboratory surveillance for Haemophilus influenzae type B meningococcal, and pneumococcal disease. Haemophilus Surveillance Working Group","volume":"89","author":"Huebner","year":"1999","journal-title":"S Afr Med J"},{"key":"10.1016\/j.vaccine.2010.11.072_bib0065","series-title":"P0302-Midyear Population Estimates","author":"Statistics South Africa","year":"2005"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2010.11.072_bib0070","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1128\/JCM.00091-09","article-title":"Genotypic comparison of invasive Neisseria meningitidis serogroup Y isolates from the United States, South Africa, and Israel, isolated from 1999 through 2002","volume":"47","author":"Whitney","year":"2009","journal-title":"J Clin Microbiol"},{"issue":"November (6)","key":"10.1016\/j.vaccine.2010.11.072_bib0075","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1128\/CDLI.5.6.845-855.1998","article-title":"Proposed standardization of Neisseria meningitidis PorA variable-region typing nomenclature","volume":"5","author":"Sacchi","year":"1998","journal-title":"Clin Diagn Lab Immunol"},{"issue":"July (Pt. 7)","key":"10.1016\/j.vaccine.2010.11.072_bib0080","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1099\/mic.0.26131-0","article-title":"Antigenic diversity of meningococcal enterobactin receptor FetA, a vaccine component","volume":"149","author":"Thompson","year":"2003","journal-title":"Microbiology"},{"issue":"March (6)","key":"10.1016\/j.vaccine.2010.11.072_bib0085","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1073\/pnas.95.6.3140","article-title":"Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms","volume":"95","author":"Maiden","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"May (9)","key":"10.1016\/j.vaccine.2010.11.072_bib0090","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1086\/597806","article-title":"Meningococcal factor H-binding protein variants expressed by epidemic capsular group A, W-135, and X strains from Africa","volume":"199","author":"Beernink","year":"2009","journal-title":"J Infect Dis"},{"issue":"April (Pt. 4)","key":"10.1016\/j.vaccine.2010.11.072_bib0095","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1099\/mic.0.2007\/014761-0","article-title":"Molecular epidemiology of meningococcal disease in England and Wales 1975\u20131995, before the introduction of serogroup C conjugate vaccines","volume":"154","author":"Russell","year":"2008","journal-title":"Microbiology"},{"issue":"April (Pt. 4)","key":"10.1016\/j.vaccine.2010.11.072_bib0100","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1099\/jmm.0.45855-0","article-title":"Prevalence of genosubtypes (PorA types) of serogroup B invasive meningococcus in the north of Spain from 2000 to 2003","volume":"54","author":"Vicente","year":"2005","journal-title":"J Med Microbiol"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2010.11.072_bib0105","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1365-3156.2007.01970.x","article-title":"Epidemiology of meningococcal disease in southern Brazil from 1995 to 2003, and molecular characterization of Neisseria meningitidis using multilocus sequence typing","volume":"13","author":"Baethgen","year":"2008","journal-title":"Trop Med Int Health"},{"issue":"November (47)","key":"10.1016\/j.vaccine.2010.11.072_bib0110","doi-asserted-by":"crossref","first-page":"5952","DOI":"10.1016\/j.vaccine.2008.08.059","article-title":"Epidemiology of pathogenic Neisseria meningitidis serogroup B serosubtypes in Malta: implications for introducing PorA based vaccines","volume":"26","author":"Pace","year":"2008","journal-title":"Vaccine"},{"issue":"March (Pt. 3)","key":"10.1016\/j.vaccine.2010.11.072_bib0115","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1099\/jmm.0.47631-0","article-title":"PorA types in Neisseria meningitidis serogroup B isolated in Argentina from 2001 to 2003: implications for the design of an outer membrane protein-based vaccine","volume":"57","author":"Sorhouet","year":"2008","journal-title":"J Med Microbiol"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2010.11.072_bib0120","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1128\/JCM.39.8.2897-2903.2001","article-title":"Serosubtypes and PorA types of Neisseria meningitidis serogroup B isolated in Brazil during 1997\u20131998: overview and implications for vaccine development","volume":"39","author":"Sacchi","year":"2001","journal-title":"J Clin Microbiol"},{"issue":"June (9580)","key":"10.1016\/j.vaccine.2010.11.072_bib0125","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1016\/S0140-6736(07)61016-2","article-title":"Epidemic meningitis, meningococcaemia, and Neisseria meningitidis","volume":"369","author":"Stephens","year":"2007","journal-title":"Lancet"},{"issue":"December (2)","key":"10.1016\/j.vaccine.2010.11.072_bib0130","first-page":"195","article-title":"Vaccine against group B Neisseria meningitidis: protection trial and mass vaccination results in Cuba","volume":"14","author":"Sierra","year":"1991","journal-title":"NIPH Ann"},{"issue":"April (16)","key":"10.1016\/j.vaccine.2010.11.072_bib0135","first-page":"1520","article-title":"Immunogenicity of 2 serogroup B outer-membrane protein meningococcal vaccines: a randomized controlled trial in Chile","volume":"281","author":"Tappero","year":"1999","journal-title":"JAMA"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2010.11.072_bib0140","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1128\/IAI.72.4.2088-2100.2004","article-title":"Vaccine potential of the Neisseria meningitidis 2086 lipoprotein","volume":"72","author":"Fletcher","year":"2004","journal-title":"Infect Immun"},{"issue":"April (16)","key":"10.1016\/j.vaccine.2010.11.072_bib0145","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1056\/NEJMra0906357","article-title":"Advances in the development of vaccines against Neisseria meningitidis","volume":"362","author":"Tan","year":"2010","journal-title":"N Engl J Med"},{"issue":"May (10)","key":"10.1016\/j.vaccine.2010.11.072_bib0150","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1086\/514821","article-title":"Prevalence of factor H-binding protein variants and NadA among meningococcal group B isolates from the United States: implications for the development of a multicomponent group B vaccine","volume":"195","author":"Beernink","year":"2007","journal-title":"J Infect Dis"},{"issue":"July","key":"10.1016\/j.vaccine.2010.11.072_bib0155","doi-asserted-by":"crossref","first-page":"6086","DOI":"10.1016\/j.vaccine.2010.06.083","article-title":"Broad vaccine coverage predicted for a bivalent recombinant factor H binding protein based vaccine to prevent serogroup B meningococcal disease","volume":"28","author":"Jiang","year":"2010","journal-title":"Vaccine"},{"issue":"March (17\u201318)","key":"10.1016\/j.vaccine.2010.11.072_bib0160","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1016\/j.vaccine.2005.01.056","article-title":"Outer membrane protein (OMP) based vaccine for Neisseria meningitidis serogroup B","volume":"23","author":"Pillai","year":"2005","journal-title":"Vaccine"},{"issue":"July (29)","key":"10.1016\/j.vaccine.2010.11.072_bib0165","doi-asserted-by":"crossref","first-page":"10834","DOI":"10.1073\/pnas.0603940103","article-title":"A universal vaccine for serogroup B meningococcus","volume":"103","author":"Giuliani","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"October","key":"10.1016\/j.vaccine.2010.11.072_bib0170","article-title":"Multicenter, open-label, randomized phase II controlled trial of an investigational recombinant meningococcal serogroup B vaccine with and without outer membrane vesicles, administered in infancy","author":"Findlow","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2010.11.072_bib0175","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1586\/14760584.8.2.135","article-title":"World vaccine congress","volume":"8","author":"Arora","year":"2009","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2010.11.072_bib0180","series-title":"17th International Pathogenic Neisseria Conference (IPNC)","article-title":"Safety & immunogenecity of serogroup B (MnB) rLP2086 vaccine in adults and adolescent subjects: overview of 3 clinical trials","author":"Richmond","year":"2010"},{"issue":"July (13)","key":"10.1016\/j.vaccine.2010.11.072_bib0185","doi-asserted-by":"crossref","first-page":"4927","DOI":"10.1073\/pnas.83.13.4927","article-title":"Intercontinental spread of a genetically distinctive complex of clones of Neisseria meningitidis causing epidemic disease","volume":"83","author":"Caugant","year":"1986","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"August (1)","key":"10.1016\/j.vaccine.2010.11.072_bib0190","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1017\/S0950268800047713","article-title":"Serotype-specific outbreak of group B meningococcal disease in Iquique, Chile","volume":"105","author":"Cruz","year":"1990","journal-title":"Epidemiol Infect"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2010.11.072_bib0195","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/j.1469-0691.2004.00935.x","article-title":"Outbreak in France of Neisseria meningitidis B:15:P1.12 belonging to sequence type 1403","volume":"10","author":"Grodet","year":"2004","journal-title":"Clin Microbiol Infect"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2010.11.072_bib0200","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1086\/517385","article-title":"New Zealand epidemic of meningococcal disease identified by a strain with phenotype B:4:P1.4","volume":"177","author":"Martin","year":"1998","journal-title":"J Infect Dis"},{"issue":"April (2)","key":"10.1016\/j.vaccine.2010.11.072_bib0205","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3201\/eid0102.950203","article-title":"Epidemic-associated Neisseria meningitidis detected by multilocus enzyme electrophoresis","volume":"1","author":"Reeves","year":"1995","journal-title":"Emerg Infect Dis"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2010.11.072_bib0210","first-page":"178","article-title":"Prolonged outbreak of B meningococcal disease in the Seine-Maritime department, France, January 2003 to June 2005","volume":"11","author":"Rouaud","year":"2006","journal-title":"Euro Surveill"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2010.11.072_bib0215","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1128\/JCM.30.7.1734-1738.1992","article-title":"Ongoing group B Neisseria meningitidis epidemic in Sao Paulo, Brazil, due to increased prevalence of a single clone of the ET-5 complex","volume":"30","author":"Sacchi","year":"1992","journal-title":"J Clin Microbiol"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2010.11.072_bib0220","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1128\/JCM.00696-07","article-title":"Deletion of the meningococcal fetA gene used for antigen sequence typing of invasive and commensal isolates from Germany: frequencies and mechanisms","volume":"45","author":"Claus","year":"2007","journal-title":"J Clin Microbiol"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2010.11.072_bib0225","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1128\/JCM.02422-06","article-title":"Deletion of fetA gene sequences in serogroup B and C Neisseria meningitidis isolates","volume":"45","author":"Marsh","year":"2007","journal-title":"J Clin Microbiol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10017160?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10017160?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,14]],"date-time":"2020-06-14T12:25:56Z","timestamp":1592137556000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X10017160"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":45,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["S0264410X10017160"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2010.11.072","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]}}}